Furthermore, TLR2 did not contribute to an effective antibacterial defense during post-influenza pneumococcal pneumonia [13], which normally is associated with a much stronger inflammatory response in the lungs than primary pneumonia [14]. The gene discussed is TLR2; the disease is pneumonia.